SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy -- Ignore unavailable to you. Want to Upgrade?

To: John S. Sturges who wrote (90)2/21/1998 10:41:00 AM
From: deadstrait  Respond to of 184
 
No personal vendetta here. If you will reread my post, you will find
that what I stated about Zenapax and PDLI was fact. Also, what I stated
about SANG was an opinion based on those facts.

Who I am is of no importance and I certainly don't claim to be guru of
any kind. However, I will not post anything unless it is factual, and
I will not start waving red flags trying to warn (scare) others on
pure speculation.

I am a firm believer in SANG. I have been in and out numerous times
since the $7 range and have made out quite well. I can say I have
never lost a dime on this one and I am in for the long hall.

When I have facts, good or bad, about Sang, I will post them.

Dead



To: John S. Sturges who wrote (90)2/21/1998 12:16:00 PM
From: deadstrait  Read Replies (1) | Respond to of 184
 
On Feb 13, 1998, H&Q reiterated their strong buy rating on SANG with
a 12 month target of $60.

Also, same day, Nationsbanc Montgomery reiterated it's "buy" rating
with a target price of $40.

I'd love to see $60 but would be very happy with $40.

IMHO--With SANG looking to be profitable by by the end of the year, I
am comfortable somewhere in between.

Dead


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News